Eisai Co.’s breakthrough Alzheimer’s drug Leqembi was cleared for use in the European Union, after the medicine was approved ...

The antibody lecanemab is the first authorized therapy in Europe that targets the underlying process of Alzheimer's, rather than only treating symptoms.

If someone with dementia isn’t hungry, you can meal prep for them and encourage them to eat small bites. Find out how to get ...

A new study found that emergency room visits and hospitalizations tied to cannabis use among older adults has skyrocketed since the early 2000s.

The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat mild cognitive impairment in the early stages of Alzheimer's disease.

Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s ...

Santa Lucia Foundation IRCCS-led research is reporting that repetitive transcranial magnetic stimulation (rTMS) targeting the precuneus may slow the progression of cognitive decline, impairments in ...

Scroll down to learn more about the challenges many caregivers face—and download Elevmi to learn more about how it can ...

People who visited the emergency department (ED) or were hospitalized due to cannabis use were at a greater risk of a new dementia diagnosis within five years, compared to individuals with an ED visit ...

Explore 6 hopeful Alzheimer’s treatment paths, from innovative therapies to promising research, offering new possibilities ...

The helmet, signed by every living world champion, will raise funds for Sir Jackie Stewart’s Race Against Dementia charity ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...